Interlaboratory comparison of high-throughput protein biomarker assay quantifications for radiation exposure classification

PLoS One. 2024 Apr 29;19(4):e0301418. doi: 10.1371/journal.pone.0301418. eCollection 2024.

Abstract

In the event of a widespread radiological incident, thousands of individuals will require rapid assessment of exposure using validated biodosimetry assays to inform clinical triage. In this scenario, multiple biodosimetry laboratories may be necessary for large-volume sample processing. To meet this need, we have developed a high-throughput assay for the rapid measurement of intracellular protein biomarkers in human peripheral blood samples using an Imaging Flow Cytometry (IFC) platform. The objective of this work was to harmonize and validate the reproducibility of our blood biomarker assay for radiation exposure across three IFC instruments, two located at Columbia University (CU) and the third at Health Canada. The Center for Radiological Research (CRR) at CU served as the central laboratory and reference instrument, where samples were prepared in triplicate, labeled with two radiation responsive leukocyte biomarkers (BAX and phosphor-p53 (Ser37)), and distributed for simultaneous interrogation by each IFC. Initial tests showed that significantly different baseline biomarker measurements were generated on each instrument when using the same acquisition settings, suggesting that harmonization of signal intensities is necessary. Subsequent tests harmonized biomarker measurements after irradiation by modulating laser intensity using two reference materials: unstained samples and standardized rainbow beads. Both methods generated measurements on each instrument without significant differences between the new and references instruments, allowing for the use of one master template to quantify biomarker expression across multiple instruments. Deming regression analyses of 0-5 Gy dose-response curves showed overall good correlation of BAX and p53 values across new and reference instruments. While Bland-Altman analyses indicated low to moderate instrument biases, ROC Curve analyses ultimately show successful discrimination between exposed and unexposed samples on each instrument (AUC values > 0.85).

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers*
  • Flow Cytometry / methods
  • High-Throughput Screening Assays / methods
  • Humans
  • Radiation Exposure* / analysis
  • Reproducibility of Results
  • Tumor Suppressor Protein p53

Substances

  • Biomarkers
  • Tumor Suppressor Protein p53

Grants and funding

“This work was funded by National Institute of Health, National Institute of Allergy and Infectious Diseases #U01AI148309, awarded to HCT. https://www.niaid.nih.gov/ Research reported in this publication using the ISX MkII imaging cytometer in the Columbia University Stem Cell Initiative Flow Cytometry core facility at Columbia University Irving Medical Center was supported by the Office of The Director, National Institutes of Health under Award Number S10OD026845. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”.